Oligodeoxynucleotide intervention for prevention and treatment of sepsis

US20050020526A1Inactive Publication Date: 2005-01-27CYTOGENIX INC

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oligodeoxynucleotide intervention for prevention and treatment of sepsis
  • Oligodeoxynucleotide intervention for prevention and treatment of sepsis
  • Oligodeoxynucleotide intervention for prevention and treatment of sepsis

Examples

Experimental program
Comparison scheme
Effect test

example 1

Development of the Mouse Sepsis Model

[0050]E. coli SM101, a temperature-sensitive UDP-N-acetylglucosamine acyltransferase mutant that lose all detectable acyltransferase activity, and its wild-type K12, were i.p. injected as described below to induce sepsis in mouse. SM101 has a defect in lipid A biosynthesis that causes the outer membrane to be permeable to high-molecular-weight substances. The lipid A content of SM101 is reduced 2-3-fold compared with the wild-type. To prepare the bacteria for mouse infection, SM101 were grown in LB medium at 37° C. Log-phase cultures of SM101 were grown to an optical density at 600 nm of 1.1 (equivalent to 5×108 CFU / ml), followed by centrifugation and resuspension in sterile phosphate-buffered saline (PBS) at 4° C. This log-phase preparation of bacteria was serially diluted in PBS, and 3×10e8 CFU of bacteria was i.p. injected to induce mouse sepsis. Serum was gathered and pro-inflammatory cytokines (IL-6, TNF, IL-1) and bacterial load tested, an...

example 2

Inhibition of Bacterial Growth by ODN

[0051] The inhibition of bacterial growth by ODN was evaluated by examining the effect of DNA dose on the ability of ODN to inhibit SM101 growth. In this study, an ODN having the sequence CTC ATA CTC T was added to the 1 / 50 diluted O / N SM101 cell cultures, at final concentration of 40 μM or 400 μM, with addition of equal volume water as a negative control, and incubated with shaking at 30° C. After 2, 4 or 6 h, the growth was measured by either the optical density at 600 nm (OD600) or viable cell count, which was done by diluting the cultures and plating them in triplicate on LB plates with streptomycin. As shown in FIG. 3, upon addition of ODN, cell growth was inhibited by 86-96%.

example 3

Inhibition of Bacterial Growth by ODN Expression Plasmid

[0052] In this study, the ODN expression plasmid As080103, having the sequence CYGXO80103 listed above, and plasmid pssxGb without ODN insert as negative control, were transformed into E. coli XL10-gold(kan). The resulting cell cultures were plated on LB media with chloramphenicol and incubated at 37° C. O / N. As shown in FIG. 4, no XL10-gold(kan) carrying ODN expression plasmid grew on the LB media.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Login to View More

Abstract

A method for producing ODNs in bacterial or fungal cells in vivo for treatment of sepsis so that, when the ODNs reach and knock down their target genes, and thereby kill bacterial or fungal cells or inhibit their growth, the bacterial or fungal accumulation in the bloodstream is held constant or diminished and the sepsis syndrome is reduced or eliminated. The invention also contemplates of certain ODNs for use in treatment of sepsis.

Description

CROSS REFERENCE TO RELATED APPLICATION [0001] The present application is a continuation-in-part of co-pending application Ser. No. 10 / 453,410, filed Jun. 3, 2003 and IDENTIFICATION OF NOVEL ANTIBACTERIAL AGENTS BY SCREENING THE SINGLE-STRANDED DNA EXPRESSION LIBRARY, and co-pending application Ser. No. 10 / 743,956, filed Dec. 23, 2003 and entitled OLIGODOXYNUCLEOTIDE (ODN) LIBRARIES, THEIR USE IN SCREENING FOR ANTIBACTERIAL AGENTS, AND CATALYTIC ODN SEQUENCE FOR USE AS AN ANTIBACTERIAL AGENT. Both of the applications listed in this paragraph are hereby incorporated into the specification of the present application in their entirety by this specific reference thereto.BACKGROUND OF THE INVENTION [0002] Severe sepsis and septic shock are life threatening complication of infections and the most common cause of death in intensive care units (Angus et al., 2001, Crit. Care Med., 29:1303-1310). Recent US and European surveys have estimated that severe sepsis accounts for 2-11% of all admiss...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
27 Jan 2005
Publication
US20050020526A1
IPC
A61K48/00; C07H21/04; C09D7/00; C12N1/21; C12N5/071; C12N5/10; C12N15/10; C12N15/113; C12N15/63; C12N15/74; C12Q1/68
CPC
C12N15/1034; C12N15/111; C12N15/113; C12N15/74; C12N2310/11; C12N2310/111; C12Q1/6837; C12N2320/11
Inventors
CHEN, YIN; TAN, XIN